Catalent Inc (NASDAQ:CTLT) was downgraded by BidaskClub from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Friday.

A number of other research firms also recently issued reports on CTLT. ValuEngine upgraded Catalent from a “hold” rating to a “buy” rating in a research note on Thursday, September 7th. Needham & Company LLC began coverage on Catalent in a research note on Tuesday. They set a “hold” rating and a $42.00 price target for the company. Zacks Investment Research downgraded Catalent from a “buy” rating to a “hold” rating in a research note on Friday, September 1st. Wells Fargo & Company reiterated an “outperform” rating and set a $39.00 price target (up previously from $30.00) on shares of Catalent in a research note on Thursday, August 31st. Finally, Bank of America Corporation reiterated a “buy” rating and set a $38.00 price target (up previously from $37.00) on shares of Catalent in a research note on Friday, July 21st. Five equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $36.80.

Shares of Catalent (CTLT) traded down 1.86% on Friday, reaching $39.49. The company had a trading volume of 2,027,367 shares. Catalent has a 12 month low of $21.83 and a 12 month high of $42.22. The stock has a market cap of $4.94 billion and a PE ratio of 45.39. The stock has a 50-day moving average price of $36.93 and a 200-day moving average price of $33.52.

Catalent (NASDAQ:CTLT) last released its quarterly earnings results on Monday, August 28th. The company reported $0.65 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.57 by $0.08. The business had revenue of $616.90 million during the quarter, compared to the consensus estimate of $547.48 million. Catalent had a return on equity of 36.29% and a net margin of 10.02%. The company’s quarterly revenue was up 15.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.52 EPS. Analysts predict that Catalent will post $1.61 earnings per share for the current fiscal year.

WARNING: “Catalent Inc (CTLT) Stock Rating Lowered by BidaskClub” was originally reported by American Banking News and is the property of of American Banking News. If you are viewing this piece of content on another domain, it was copied illegally and republished in violation of U.S. & international copyright laws. The legal version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/09/16/catalent-inc-ctlt-stock-rating-lowered-by-bidaskclub.html.

In other news, SVP Christine Dolan sold 745 shares of the business’s stock in a transaction that occurred on Tuesday, August 1st. The stock was sold at an average price of $34.85, for a total value of $25,963.25. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Hedge funds and other institutional investors have recently made changes to their positions in the company. Flinton Capital Management LLC boosted its stake in shares of Catalent by 17.7% in the 1st quarter. Flinton Capital Management LLC now owns 3,616 shares of the company’s stock worth $102,000 after buying an additional 544 shares during the last quarter. Acrospire Investment Management LLC boosted its stake in shares of Catalent by 72.2% in the 2nd quarter. Acrospire Investment Management LLC now owns 3,100 shares of the company’s stock worth $109,000 after buying an additional 1,300 shares during the last quarter. Quantbot Technologies LP boosted its stake in shares of Catalent by 110.7% in the 2nd quarter. Quantbot Technologies LP now owns 3,434 shares of the company’s stock worth $120,000 after buying an additional 1,804 shares during the last quarter. Meadow Creek Investment Management LLC boosted its stake in shares of Catalent by 17.7% in the 1st quarter. Meadow Creek Investment Management LLC now owns 4,972 shares of the company’s stock worth $141,000 after buying an additional 748 shares during the last quarter. Finally, Acadian Asset Management LLC boosted its stake in shares of Catalent by 115.7% in the 1st quarter. Acadian Asset Management LLC now owns 5,847 shares of the company’s stock worth $166,000 after buying an additional 3,136 shares during the last quarter.

About Catalent

Catalent, Inc provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. Its segments include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of prescription and consumer health soft capsules or softgels.

Analyst Recommendations for Catalent (NASDAQ:CTLT)

Receive News & Ratings for Catalent Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catalent Inc and related companies with MarketBeat.com's FREE daily email newsletter.